82 - Incidence rates of invasive aspergillosis among lung transplant recipients in timeperiods with universal and targeted antifungal prophylaxis - a nationwide cohort study

Thursday, October 20, 2022

10:45 AM – 11:00 AM US ET

Location: 103 AB

Watch the live stream on the conference website.

All relevant financial disclosures have been mitigated.

Co-Author(s)

CC

Cornelia G. Crone, MD

PhD-fellow
Rigshospitalet, Copenhagen University Hospital
Copehagen N, Hovedstaden, Denmark

Disclosure: Disclosure(s): No financial relationships to disclose

Presenting Author(s)

Signe Marie Wulff, BSc. Medicine

Pregraduate Research Scholar
CHIP -Centre of Excellence for Health, Immunity and Infections, Rigshospitalet
Copenhagen, Hovedstaden, Denmark

Disclosure: Disclosure(s): No financial relationships to disclose

Slides

Co-Author(s)

BL

Bruno Ledergerber, PhD

Senior Reseracher
Rigshospitalet, University of Copenhagen
Rorbas, Zurich, Switzerland

Disclosure: Disclosure(s): No financial relationships to disclose
PB

Pia Bredahl, K, MD

Rigshospitalet
Copenhagen, Hovedstaden, Denmark

Disclosure: Disclosure(s): No financial relationships to disclose
JH

Jannik Helweg-Larsen, MD, DMSc

Rigshospitalet, Copenhagen University Hospital
Copenhagen, Hovedstaden, Denmark

Disclosure: Disclosure(s): No financial relationships to disclose
MA

Maiken C. Arendrup, DMSci, PhD, MD

Prof., Head of Unit
Statens Serum Institut
Copenhagen, Hovedstaden, Denmark

Disclosure: Disclosure(s): Chiesi, Gilead: Honoraria (); F2G, Cidara, Scynexis: Grant/Research Support ()
MP

Michael Perch, MD

Associate Clinical Professor
University of Copenhagen
Copenhagen, Hovedstaden, Denmark

Disclosure: Disclosure(s): Boeringer-Ingelheim: Travel grant (); PulmonX: Expert Testimony (); Roche: Grant/Research Support (); Takeda: Expert Testimony (); Therakos: Honoraria (); Zambon: Advisor/Consultant (), Expert Testimony ()
MH

Marie Helleberg, PhD, DMSc

Consultant
Rigshospitalet, Copenhagen University Hospital
Copenhagen, Hovedstaden, Denmark

Disclosure: Disclosure(s): AstraZeneca: Advisor/Consultant (); Gilead: Advisor/Consultant (), Honoraria (); GSK: Advisor/Consultant (), Honoraria (); Janssen: Advisor/Consultant (); Roche: Advisor/Consultant (); Sobi: Advisor/Consultant ()

Disclosure(s):

Cornelia G. Crone, MD: No financial relationships to disclose

Signe Marie Wulff, BSc. Medicine: No financial relationships to disclose

Bruno Ledergerber, PhD: No financial relationships to disclose

Pia Bredahl, MD, K: No financial relationships to disclose

Jannik Helweg-Larsen, MD, DMSc: No financial relationships to disclose

Maiken C. Arendrup, DMSci, PhD, MD: Chiesi, Gilead: Honoraria (); F2G, Cidara, Scynexis: Grant/Research Support ()

Michael Perch, MD: Boeringer-Ingelheim: Travel grant (); PulmonX: Expert Testimony (); Roche: Grant/Research Support (); Takeda: Expert Testimony (); Therakos: Honoraria (); Zambon: Advisor/Consultant (), Expert Testimony ()

Marie Helleberg, PhD, DMSc: AstraZeneca: Advisor/Consultant (); Gilead: Advisor/Consultant (), Honoraria (); GSK: Advisor/Consultant (), Honoraria (); Janssen: Advisor/Consultant (); Roche: Advisor/Consultant (); Sobi: Advisor/Consultant ()